Sort
21,281 grants matching “influenza”
Balancing Immunogenicity of a Tetravalent Live Attenuated Dengue Vaccine
$222,698Steffen Mueller · Codagenix, Inc. · R43 · FY2015 · AI
Production , purification and preparation of various candidiate vaccines
$222,521Joseph Shiloach · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2014 · DK
The role of Ig Polymorphism in shaping the Broadly Neutralizing Antibody Response to Hemagglutinin HA stem domain(s) of Influenza A, Group 1 and 2 Viruses
$222,500Wayne A. Marasco · Dana-Farber Cancer Inst · R21 · FY2020 · AI
Antigen-independent activation of memory CD8 T cells during respiratory infection
$222,500Jacob E Kohlmeier · Trudeau Institute, Inc. · R21 · FY2009 · AI
Depots of persistent influenza antigens support protective CD4 T cell memory
$222,500Dawn M Jelley-Gibbs · Trudeau Institute, Inc. · R21 · FY2009 · AI
Integrase-defective lentiviral based influenza vaccines
$222,363Mirella Salvatore · Weill Medical Coll Of Cornell Univ · R21 · FY2010 · AI
Respiratory Virus Ion Channels
$222,332Northwestern University · R01 · FY2003 · AI
Optimization of AO drugs 45, 51 & 53
$222,306Eric P Hoffman · Children'S Research Institute · P50 · FY2012 · AR
Protein Core
$222,301Gerard Zurawski · Baylor Research Institute · U19 · FY2011 · AI
Development of novel broad-spectrum influenza A inhibitors
$222,059Ken J McCormack · Arisan Therapeutics, Inc. · R43 · FY2012 · AI
Respiratory Virus Ion Channels
$222,023Northwestern University · R01 · FY2004 · AI
Respiratory Virus Ion Channels
$222,023Northwestern University · R01 · FY2005 · AI
Application of MR Spectroscopy Techniques to Animal Models of Obstetric Complicat
$222,000April Elizabeth Ronca · Wake Forest University Health Sciences · R21 · FY2008 · HD
Immune factors in vaccine-enhanced pandemic H1N1 influenza disease
$222,000Matthew R Sandbulte · Iowa State University · R21 · FY2013 · AI
CD8 T Cell Response to Influenza Virus Infection
$222,000Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · R21 · FY2007 · AI
Telomere loss and T cell aging in HBV vaccine response in HIV-infected individual
$222,000Zhi Q. Yao · East Tennessee State University · R21 · FY2018 · AI
Long Term Effects of Influenza Virus on T Cell Migration
$222,000Linda S Cauley · University Of Connecticut Sch Of Med/Dnt · R21 · FY2006 · AI
Pilot and Exploratory Studies Core
$221,983Albert C Shaw · Yale University · P30 · FY2022 · AG
Extracellular vesicles encapsulating CRISPR machinery for treatment of SARS-CoV-2 infection
$221,972Houjian Cai · University Of Georgia · R21 · FY2023 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$221,905Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
RESPIRATORY VIRUS NEUTRALIZATION BY INTRACELLULAR AB
$221,888Vanderbilt University · R21 · FY2001 · DE
Development of novel protease inhibitors for influenza and paramyxoviruses
$221,875Gary R Whittaker · Cornell University · R21 · FY2016 · AI
REGULATION OF CYTOKINE GENES IN MUCOSAL VIRAL INFECTION
$221,754University Of Texas Medical Br Galveston · R01 · FY2000 · AI
Programming of Protective CD8 T-Cell Memory by Live and Adjuvanted Subunit Vaccin
$221,710Marulasiddappa Suresh · University Of Wisconsin-Madison · R21 · FY2012 · AI
Mechanism-guided drug repurposing for host-directed therapy of infectious diseases using interpretable and integrative ML
$221,694Arjun Krishnan · University Of Colorado Denver · R21 · FY2022 · AI